Qube Research & Technologies (QRT)
CVS icon

Qube Research & Technologies (QRT)’s CVS Health CVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154M Buy
2,150,366
+516,220
+32% +$39.8M 0.17% 126
2025
Q4 		$130M Buy
+1,634,146
New +$129M 0.13% 168
2025
Q3 		– Sell
-130,777
Closed -$8.96M – 3640
2025
Q2 		$9.02M Buy
+130,777
New +$8.58M 0.01% 1350
2025
Q1 		– Sell
-1,518
Closed -$90.8K – 3546
2024
Q4 		$68.1K Buy
+1,518
New +$85.2K ﹤0.01% 3056
2024
Q3 		– Sell
-36,372
Closed -$2.12M – 3457
2024
Q2 		$2.15M Buy
36,372
+34,676
+2,045% +$2.17M ﹤0.01% 1582
2024
Q1 		$135K Sell
1,696
-4,390
-72% -$335K ﹤0.01% 3194
2023
Q4 		$481K Sell
6,086
-8,726
-59% -$621K ﹤0.01% 2311
2023
Q3 		$1.03M Sell
14,812
-1,867,185
-99% -$132M ﹤0.01% 1714
2023
Q2 		$130M Buy
1,881,997
+206,176
+12% +$14.7M 0.47% 35
2023
Q1 		$125M Buy
1,675,821
+738,681
+79% +$61.9M 0.54% 12
2022
Q4 		$87.3M Buy
937,140
+776,953
+485% +$75M 0.47% 21
2022
Q3 		$15.3M Sell
160,187
-262,196
-62% -$26M 0.09% 301
2022
Q2 		$39.1M Sell
422,383
-129,423
-23% -$12.6M 0.29% 70
2022
Q1 		$55.8M Buy
551,806
+442,953
+407% +$46.5M 0.47% 27
2021
Q4 		$11.2M Buy
+108,853
New +$10.1M 0.09% 311
2021
Q3 		– Sell
-123,785
Closed -$10.3M – 2310
2021
Q2 		$10.3M Buy
123,785
+36,405
+42% +$2.98M 0.12% 201
2021
Q1 		$6.57M Sell
87,380
-120,675
-58% -$8.79M 0.1% 243
2020
Q4 		$14.2M Buy
208,055
+114,829
+123% +$7.47M 0.2% 93
2020
Q3 		$5.44M Buy
+93,226
New +$5.8M 0.08% 332
2019
Q3 		– Sell
-27,551
Closed -$1.5M – 290
2019
Q2 		$1.5M Sell
27,551
-10,316
-27% -$556K 0.36% 72
2019
Q1 		$2.04M Buy
37,867
+22,248
+142% +$1.37M 0.27% 89
2018
Q4 		$1.02M Buy
15,619
+498
+3% +$37.2K 0.44% 35
2018
Q3 		$1.19M Sell
15,121
-11,315
-43% -$809K 0.16% 106
2018
Q2 		$1.7M Buy
26,436
+22,991
+667% +$1.52M 1.07% 10
2018
Q1 		$214K Buy
+3,445
New +$247K 0.08% 153

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CVS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its CVS Health (CVS) stake by 32% in Q1 2026, buying an estimated $39.8M and bringing the position to 2,150,366 shares worth $154M. The position accounts for 0.17% of the portfolio, ranked #126.

Qube Research & Technologies (QRT) first reported a position in CVS in Q1 2018 and has held it in 25 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,150,366 shares of CVS Health worth $154M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 516,220 CVS Health shares in Q1 2026, an estimated $39.8M.
  • CVS Health made up 0.17% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #126 holding.
  • Qube Research & Technologies (QRT) first reported a position in CVS Health in Q1 2018 and has held it in 25 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.